CEO pay: Who makes what in Big Biotech?

What do you get when you make it to the top of Big Biotech's biggest companies? Millions in compensation, for one thing. But although the average pay for the CEOs listed is $14.42 million, most saw a decline from 2006 levels, underscoring the stock market challenges some biotechs faced in 2007. Take, for instance, Amgen CEO Kevin Sharer. Though he came out on top in this year's CEO pay ranking, Sharer's pay down 17 percent from 2006. His base salary was up slightly to $1.55 million but he took a hit on stock awards and incentive plan compensation.

Because companies each have their own approach to reporting CEO pay, FierceBiotech's numbers are based on total compensation reported in these companies SEC filings. The numbers include base salary, bonus and "other" compensation in 2007. Click below to see what biotech's biggest players made last year.

1. Kevin Sharer - Amgen

2. Arthur Levinson - Genentech

3. Henri Treemer - Genzyme

4. John Martin - Gilead

5. James Mullen - Biogen Idec


Suggested Articles

The data, from two patients with severe blood disorders, are "promising” for what could be a one-and-done treatment, Cantor Fitzgerald analysts wrote.

The fund will back pharma companies as well as developers of medtech products and providers of outsourced services.

The money will fund work to develop polymers in multiple indications and an associated U.S. expansion.